Clinical Trials in Dallas

Showing 11061-11080 of 17,468 trials

A Multicenter, Double-blind, Randomized, Parallel-group, Pilot Study of 12-week Duration to Assess the Short-term Safety and Tolerability of Lorcaserin Plus Two Doses of Immediate-Release Phentermine-HCl Compared With Lorcaserin Alone in Overweight and Obese Adults

NCT01987427

APD356-A001-402 is a multicenter, double-blind, randomized, parallel-group pilot study of 12-week duration in overweight and obese adults. Approximately 225 subjects will be randomized to one of three treatment arms in a ratio 1:1:1 and will receive the combinations of lorcaserin 10 mg twice daily (BID) plus immediate-release phentermine-HCl 15 mg BID or 15 mg once daily (QD), or lorcaserin alone.

Chronic Weight Management

Eisai Inc.344 participantsStarted Oct 2013

Birmingham, Alabama, United States • Chandler, Arizona, United States • La Jolla, California, United States +10 more locations

COMPLETEDPhase 3< 1 mile

Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III

NCT01827046

A phase III, randomized, case-controlled, open-label, 500-subject clinical trial of minimally invasive surgery plus rt-PA in the treatment of intracerebral hemorrhage (ICH).

Intracerebral Hemorrhage

Johns Hopkins University499 participantsStarted Dec 2013

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +81 more locations

A Multicenter, Double-blind, Randomized, Parallel-group, Pilot Study of 12-week Duration to Assess the Short-term Safety and Tolerability of Lorcaserin Plus Two Doses of Immediate-Release Phentermine-HCl Compared With Lorcaserin Alone in Overweight and Obese Adults

Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III

Find Trials by Condition in Dallas

The LIVMOR Data Collection Study for the Development and Validation of L-1000AF System

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI)

Safety and Efficacy of the Vibrant Soundbridge (VSB) for Mixed and Conductive Hearing Losses

A Study of Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based Chemotherapy

A Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Participants With Geographic Atrophy

An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses

Study of Ramucirumab in Ovarian Cancer

Clinical Evaluation of 3 Contact Lens Materials With 3 Solution Types

A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease

A Study in Advanced Solid Tumors

Open Label Extension Study to Evaluate the Long-term Safety of Zorblisa (SD-101-6.0) in Patients With Epidermolysis Bullosa

Efficacy and Safety Study of VB-1953 Topical Gel for Inflammatory Facial Acne Vulgaris

Evaluation of the CooperVision, Inc. Fanfilcon A and Enfilcon A Daily Wear Contact Lenses When Used for Frequent Replacement for up to One (1) Month of Daily Wear

Efficacy and Safety of Daclizumab in Participants With RRMS Switching From Natalizumab

Safety and Feasibility of ADRCs Treatment To Patients With Thermal Wounds

Novel PI3K Delta Inhibitor TGR-1202, in Combination With Brentuximab Vedotin for Hodgkin's Lymphoma Patients

Study of RTXM83 Plus CHOP Chemotherapy Versus a Rituximab Plus CHOP Therapy in Patients With Non Hodgkin's Lymphoma